-2.75 (-0.17%) Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma (Netherlands) BV has increased its shareholding in PJSC Biosintez, Russia, by way of purchase of 8698 shares equivalent to 3.04% of PJSC Biosintez under Mandatory Tender Offer.
Post completion of this purchase of shares, the total holding of wholly owned subsidiary company was increased from 96.96% to 100% in PJSC Biosintez.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.